IVF patients suing over inaccurate genetic tests find out some of their embryos were not discarded

Some people involved in a class action against two fertility services over the use of a non-invasive test which may have incorrectly classified embryos as abnormal have been told their embryos are still being stored. Key points: Monash IVF and Repromed found out a non-invasive method to test embryos was inaccurate At the time, they told patients they could destroy them or donate them to science They now say some of those embryos may be viable The lawyer representing about 200 affected parties in Victoria's Supreme Court said the mistake had resulted in some women choosing to be implanted with another person's embryo, while others have lost precious months of fertility. The class action launched last December alleges Melbourne-based Monash IVF and Adelaide-based Repromed breached their duty of care by failing to tell patients about the pitfalls of a type of testing that does not require a biopsy. "What we're trying to do is say, look, unfortunately, we've now recognised that the test is not as accurate as it was originally portrayed to us and that we want to give these individuals the opportunity to make a decision now what they want to do with those embryos," he told ABC Radio Adelaide.